Shanda Group is a global, privately-owned investment firm that focuses on two primary areas: truly disruptive technologies at an early developmental stage and undervalued publicly listed companies with significant turnaround potential. Their venture capital strategy specifically targets human-oriented deep technologies such as gene-editing, robotics, anti-aging, brain-related research, and innovative artificial intelligence.
They made 1 investments in the last 12 months. Their most common stage is series-a (50% of deals). Average disclosed round size is $35.5M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$8B
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| TTrener Robotics | Series A | $32M | Feb 2026 |
| IIota Biosciences | Series A | $15M | May 2018 |
| LLumus | Series C | $45M | Dec 2016 |
 Survios | Series C | $50M | Dec 2016 |
Top Co-Investors
Horizon Ventures1 shared
Astellas Venture Management1 shared
Bold Capital Partners1 shared
HTC1 shared
Lux Capital1 shared
Felicis Ventures1 shared
Shasta1 shared
Danhua Capital1 shared
Dentsu Ventures1 shared
The Engine1 shared
IAG Capital Partners1 shared
Cadence Growth Capital1 shared
Geodesic Capital1 shared
Emergent Ventures1 shared
Fitz Gate Ventures1 shared
Radius Capital1 shared
Last updated: 16 April 2026